- Home
- » Tags
- » Dexchlorpheniramine
Top View
- Ep 2301628 A1
- Clemastine, the H1 Histamine Receptor Antagonist, Alters the Human Sex and Thyroid Hormonal Profiles
- Dexchlorpheniramine Maleate Oral Solution, USP Rx Only
- (12) United States Patent (Lo) Patent No.: US 8,480,637 B2
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Antihistamines and Driving-Related Behavior: a Review of the Evidence for Impairment by First- Versus Second-Generation H1-Antagonists
- Antihistamines
- Mebhydrolin Napadisylate
- Use of Combinations Comprising a Corticosteroid and a Pyrimidopyrimidine in the Treatment of Inflammatory Diseases
- Potentially Harmful Drugs in the Elderly: Beers List and More
- Prescribing Focus
- Medications to Avoid in the Elderly Adapted from NCQA’S HEDIS® Measure, Use of High-Risk Medications in the Elderly
- Photosensitizing Drugs
- Our Parents, Ourselves: Health Care for an Aging Population
- Patient Information Leaflet
- Management of Drug Overdose and Poisoning
- CMS: High-Risk Medications (Relevant for Older People Defined As Greater Than 65 Years of Age)
- Medications That Interfere with Skin Testing If Possible, STOP the Following Medications for ONE WEEK Prior to Your Appointment If Skin Testing Needs to Be Performed
- Toxicology Brief” Was Contributed by Lisa Murphy, VMD, ASPCA Animal Poison Control Center, 1717 S
- Medication Alternatives for the Elderly 5/30/08 the Following Table Details the Drugs to Avoid and the Recommended Agents to Be Considered As Alternatives.*
- Data Sheet 17 February 2020 New Zealand Data Sheet
- High Risk Medications
- Attachment 2
- Dexchlorpheniramine Maleate Liquid CARWIN PHARMACEUTICAL ASSOCIATES, LLC ------RYCLORA™ (Dexchlorpheniramine Maleate) Oral Solution, USP Rx Only
- Child Registration Forms
- (12) United States Patent (10) Patent No.: US 6,790,980 B1 Venkataraman (45) Date of Patent: Sep
- Dexchlorpheniramine Maleate
- Dexchlorpheniramine Oral Solution)
- Harmonized Tariff Schedule of the United States (2006) (Rev
- Antihistamines in Topical Preparations
- (12) Patent Application Publication (10) Pub. No.: US 2014/0094438 A1 Mitchell (43) Pub
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- 2020 List of High-Risk Medications (DAE)
- Food and Drug Administration, HHS § 341.72
- ANTI-HISTAMINE (Tablets, Chewables, Syrup, Nose Sprays, Eye Drops & Over the Counter) THIS IS the LIST of MEDICATIONS YOU NEED to AVOID
- Healthpartners List of Potentially Inappropriate Medications for the Elderly
- Allergy and Asthma Clinic of Central Texas
- Antihistamines and Driving Ability: Evidence from On-The-Road Driving Studies During Normal Traffic Joris C
- Photosensitizing Medication List Medication Photosensitizing Amitriptyline Light
- Antihistamines ― Oral Prior Authorization of Benefits Form
- Polaramine CMI 9 October 2017 Consumer Medicine Information
- Medicines That Affect Allergy Skin Testing
- Use of High-Risk Medications in the Elderly Emeasure 156 Emeasure 6.4.000 Identifier Version (Measure Number Authoring Tool)
- MSM Cross Reference AD 070109(Final & Corrected)
- Medications Check List
- Allergy Skin Testing Medications to Avoid
- Important Medication Information for Allergy Testing
- Section 3: Antiallergics and Medicines Used in Anaphylaxis
- Sedating Antihistamines
- Pocket Guide to High-Risk Medications in the Elderly
- Medicines Adverse Reactions Committee Meeting Date 11 June 2020 Agenda Item 3.2.3
- Classification of Sedating Antihistamines
- Supplemental Material
- Prescribing of Potentially Inappropriate Psychotropic
- Anticholinergic Medications in Older Adults
- Deprescribing Guide for Sedating Antihistamines
- Potentially Inappropriate Medications in Older Adults According the Beers
- Skin Testing Instructions